Low expression of Beclin 1, associated with high Bcl-xL, predicts a malignant phenotype and poor prognosis of gastric cancer

Autophagy

Volumn 8, Issue 3, 2012, Pages 389-400

  Zhou, Wei Hua ^a,b   Tang, Fang ^a   Xu, Jie ^b   Wu, Xing ^a,b   Yang, Shao Bing ^c   Feng, Zhi Ying ^a   Ding, Yun Gang ^a   Wan, Xiang Bo ^a   Guan, Zhong ^a   Li, Hai Gang ^a   Lin, Dong Jun ^a   Shao, Chun Kui ^a   Liu, Quentin ^a,b  

^a SUN YAT SEN UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^c HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Apoptosis; Autophagy; Bcl xL; Beclin 1; Biomarker; Gastric cancer; Prognosis

Indexed keywords

BECLIN 1; PROTEIN BCL XL;

ADULT; AGED; ARTICLE; AUTOPHAGY; CANCER CELL CULTURE; CANCER GROWTH; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; MALE; OVERALL SURVIVAL; PHENOTYPE; PROGRESSION FREE SURVIVAL; PROTEIN EXPRESSION; RECEIVER OPERATING CHARACTERISTIC; STOMACH CANCER; TUMOR DIFFERENTIATION;

EID: 84859142474     PISSN: 15548627     EISSN: 15548635     Source Type: Journal    
DOI: 10.4161/auto.18641     Document Type: Article

References (42)

1. Dicken BJ, Bigam DL, Cass C, Mackey JR, Joy AA, Hamilton SM. Gastric adenocarcinoma: review and considerations for future directions. Ann Surg 2005; 241:27-39; PMID:15621988
2. Macdonald JS, Smalley SR, Benedetti J, Hundahl SA, Estes NC, Stemmermann GN, et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 2001; 345:725-30; PMID: 11547741; http://dx.doi.org/10.1056/NEJMoa010187
3. Zheng L, Wang L, Ajani J, Xie K. Molecular basis of gastric cancer development and progression. Gastric Cancer 2004; 7:61-77; PMID:15224192; http://dx. doi.org/10.1007/s10120-004-0277-4
4. Zhang XW, Sheng YP, Li Q, Qin W, Lu YW, Cheng YF, et al. BMI1 and Mel-18 oppositely regulate carcinogenesis and progression of gastric cancer. Mol Cancer 2010; 9:40; PMID:20170541; http://dx.doi. org/10.1186/1476-4598-9-40
5. de Maat MF, van de Velde CJ, Umetani N, de Heer P, Putter H, van Hoesel AQ, et al. Epigenetic silencing of cyclooxygenase-2 affects clinical outcome in gastric cancer. J Clin Oncol 2007; 25:4887-94; PMID: 17971584; http://dx.doi.org/10.1200/JCO.2006.09.8921
6. Hayashi M, Inokuchi M, Takagi Y, Yamada H, Kojima K, Kumagai J, et al. High expression of HER3 is associated with a decreased survival in gastric cancer. Clin Cancer Res 2008; 14:7843-9; PMID:19047113; http://dx.doi.org/10. 1158/1078-0432.CCR-08-1064
7. Chatterjee D, Sabo E, Tavares R, Resnick MB. Inverse association between Raf Kinase Inhibitory Protein and signal transducers and activators of transcription 3 expression in gastric adenocarcinoma patients: implications for clinical outcome. Clin Cancer Res 2008; 14: 2994-3001; PMID:18483365; http://dx.doi.org/10. 1158/1078-0432.CCR-07-4496
8. Zhao ZS, Wang YY, Chu YQ, Ye ZY, Tao HQ. SPARC is associated with gastric cancer progression and poor survival of patients. Clin Cancer Res 2010; 16: 260-8; PMID:20028745; http://dx.doi.org/10.1158/1078-0432.CCR-09-1247
9. De Vita F, Giuliani F, Silvestris N, Catalano G, Ciardiello F, Orditura M. Human epidermal growth factor receptor 2 (HER2) in gastric cancer: a new therapeutic target. Cancer Treat Rev 2010; 36(Suppl 3):S11-5; PMID: 21129604; http://dx.doi.org/10.1016/S0305-7372(10)70014-1
10. Bang YJ, Van Cutsem E, Feyereislova A, Chung HC, Shen L, Sawaki A, et al. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastrooesophageal junction cancer (ToGA): a phase 3, openlabel, randomised controlled trial. Lancet 2010; 376: 687-97; PMID:20728210; http://dx.doi.org/10.1016/S0140-6736(10)61121-X
11. Kroemer G, Jaattela M. Lysosomes and autophagy in cell death control. Nature reviews 2005; 5:886-97. (Pubitemid 41746033)
12. Klionsky DJ, Emr SD. Autophagy as a regulated pathway of cellular degradation. Science (New York, NY 2000; 290:1717-21.
13. Mizushima N, Levine B, Cuervo AM, Klionsky DJ. Autophagy fights disease through cellular self-digestion. Nature 2008; 451:1069-75; PMID:18305538; http://dx.doi.org/10.1038/nature06639
14. Liu Y, Schiff M, Czymmek K, Talloczy Z, Levine B, Dinesh-Kumar SP. Autophagy regulates programmed cell death during the plant innate immune response. Cell 2005; 121:567-77; PMID:15907470; http://dx. doi.org/10.1016/j. cell.2005.03.007
15. Lum JJ, Bauer DE, Kong M, Harris MH, Li C, Lindsten T, et al. Growth factor regulation of autophagy and cell survival in the absence of apoptosis. Cell 2005; 120:237-48; PMID:15680329; http://dx.doi.org/10.1016/j.cell.2004.11. 046
16. Colell A, Ricci JE, Tait S, Milasta S, Maurer U, Bouchier-Hayes L, et al. GAPDH and autophagy preserve survival after apoptotic cytochrome c release in the absence of caspase activation. Cell 2007; 129:983-97; PMID:17540177; http://dx.doi.org/10.1016/j.cell.2007.03.045
17. Zeng X, Overmeyer JH, Maltese WA. Functional specificity of the mammalian Beclin-Vps34 PI 3-kinase complex in macroautophagy versus endocytosis and lysosomal enzyme trafficking. J Cell Sci 2006; 119:259-70; PMID:16390869; http://dx.doi.org/10.1242/jcs. 02735
18. Liang XH, Jackson S, Seaman M, Brown K, Kempkes B, Hibshoosh H, et al. Induction of autophagy and inhibition of tumorigenesis by beclin 1. Nature 1999; 402:672-6; PMID:10604474; http://dx.doi.org/10.1038/45257
19. Aita VM, Liang XH, Murty VV, Pincus DL, Yu W, Cayanis E, et al. Cloning and genomic organization of beclin 1, a candidate tumor suppressor gene on chromosome 17q21. Genomics 1999; 59:59-65; PMID: 10395800; http://dx.doi.org/10. 1006/geno.1999.5851
20. Qu X, Yu J, Bhagat G, Furuya N, Hibshoosh H, Troxel A, et al. Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene. J Clin Invest 2003; 112:1809-20; PMID:14638851
21. Yue Z, Jin S, Yang C, Levine AJ, Heintz N. Beclin 1, an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor. Proc Natl Acad Sci USA 2003; 100:15077-82; PMID: 14657337; http://dx.doi.org/10.1073/pnas.2436255100
22. Pattingre S, Tassa A, Qu X, Garuti R, Liang XH, Mizushima N, et al. Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy. Cell 2005; 122:927-39; PMID:16179260; http://dx.doi.org/10.1016/j.cell.2005.07.002
23. Maiuri MC, Le Toumelin G, Criollo A, Rain JC, Gautier F, Juin P, et al. Functional and physical interaction between Bcl-X(L) and a BH3-like domain in Beclin-1. EMBO J 2007; 26:2527-39; PMID: 17446862; http://dx.doi.org/10.1038/sj. emboj.7601689
24. Oberstein A, Jeffrey PD, Shi Y. Crystal structure of the Bcl-XL-Beclin 1 peptide complex: Beclin 1 is a novel BH3-only protein. J Biol Chem 2007; 282: 13123-32; PMID:17337444; http://dx.doi.org/10.1074/jbc.M700492200
25. Karantza-Wadsworth V, Patel S, Kravchuk O, Chen G, Mathew R, Jin S, et al. Autophagy mitigates metabolic stress and genome damage in mammary tumorigenesis. Genes Dev 2007; 21:1621-35; PMID:17606641; http://dx.doi.org/10. 1101/gad.1565707
26. Mathew R, Kongara S, Beaudoin B, Karp CM, Bray K, Degenhardt K, et al. Autophagy suppresses tumor progression by limiting chromosomal instability. Genes Dev 2007; 21:1367-81; PMID:17510285; http://dx.doi.org/10.1101/gad.1545107
27. Ding ZB, Shi YH, Zhou J, Qiu SJ, Xu Y, Dai Z, et al. Association of autophagy defect with a malignant phenotype and poor prognosis of hepatocellular carcinoma. Cancer Res 2008; 68:9167-75; PMID:19010888; http://dx.doi.org/10. 1158/0008-5472.CAN-08-1573
28. Yokozaki H. Molecular characteristics of eight gastric cancer cell lines established in Japan. Pathol Int 2000; 50:767-77; PMID:11107048; http://dx.doi.org/10. 1046/j.1440-1827.2000.01117.x
29. Zou XM, Li YL, Wang H, Cui W, Li XL, Fu SB, et al. Gastric cancer cell lines induced by trichostatin A. World J Gastroenterol 2008; 14:4810-5; PMID:18720545; http://dx.doi.org/10.3748/wjg.14.4810
30. Wang J. Beclin 1 bridges autophagy, apoptosis and differentiation. Autophagy 2008; 4:947-8; PMID: 18769161
31. Shen Y, Li DD, Wang LL, Deng R, Zhu XF. Decreased expression of autophagy-related proteins in malignant epithelial ovarian cancer. Autophagy 2008; 4:1067-8; PMID:18776739
32. Miracco C, Cosci E, Oliveri G, Luzi P, Pacenti L, Monciatti I, et al. Protein and mRNA expression of autophagy gene Beclin 1 in human brain tumours. Int J Oncol 2007; 30:429-36; PMID:17203225
33. Shi YH, Ding ZB, Zhou J, Qiu SJ, Fan J. Prognostic significance of Beclin 1-dependent apoptotic activity in hepatocellular carcinoma. Autophagy 2009; 5:380-2; PMID:19145109; http://dx.doi.org/10.4161/auto.5.3.7658
34. Li BX, Li CY, Peng RQ, Wu XJ, Wang HY, Wan DS, et al. The expression of beclin 1 is associated with favorable prognosis in stage IIIB colon cancers. Autophagy 2009; 5:303-6; PMID:19066461; http://dx.doi.org/10.4161/auto.5.3.7491
35. Wan XB, Fan XJ, Chen MY, Xiang J, Huang PY, Guo L, et al. Elevated Beclin 1 expression is correlated with HIF- 1alpha in predicting poor prognosis of nasopharyngeal carcinoma. Autophagy 2010; 6:395-404; PMID: 20150769; http://dx.doi.org/10.4161/auto.6.3.11303
36. Wang J, Lian H, Zhao Y, Kauss MA, Spindel S. Vitamin D3 induces autophagy of human myeloid leukemia cells. J Biol Chem 2008; 283:25596-605; PMID:18628207; http://dx.doi.org/10.1074/jbc.M801716200
37. Maiuri MC, Criollo A, Tasdemir E, Vicencio JM, Tajeddine N, Hickman JA, et al. BH3-only proteins and BH3 mimetics induce autophagy by competitively disrupting the interaction between Beclin 1 and Bcl-2/ Bcl-X(L). Autophagy 2007; 3:374-6; PMID:17438366
38. Lian J, Wu X, He F, Karnak D, Tang W, Meng Y, et al. A natural BH3 mimetic induces autophagy in apoptosis-resistant prostate cancer via modulating Bcl- 2-Beclin1 interaction at endoplasmic reticulum. Cell Death Differ 2011; 18:60-71; PMID:20577262; http://dx.doi.org/10.1038/cdd.2010.74
39. Tian S, Lin J, Jun Zhou J, Wang X, Li Y, Ren X, et al. Beclin 1-independent autophagy induced by a Bcl-XL/ Bcl-2 targeting compound, Z18. Autophagy 2010; 6: 1032-41; PMID:20818185; http://dx.doi.org/10.4161/auto.6.8. 13336
40. Chen C, Ma Q, Ma X, Liu Z, Liu X. Association of Elevated HIF-2alpha Levels with Low Beclin 1 Expression and Poor Prognosis in Patients with Chondrosarcoma. Ann Surg Oncol 2011; 18:2364-72; PMID:21327823; http://dx.doi.org/10.1245/s10434-011-1587-5
41. Xie D, Sham JS, Zeng WF, Lin HL, Che LH, Wu HX, et al. Heterogeneous expression and association of betacatenin, p16 and c-myc in multistage colorectal tumorigenesis and progression detected by tissue microarray. Int J Cancer 2003; 107:896-902; PMID:14601048; http://dx.doi.org/10.1002/ijc.11514
42. Zlobec I, Steele R, Terracciano L, Jass JR, Lugli A. Selecting immunohistochemical cut-off scores for novel biomarkers of progression and survival in colorectal cancer. J Clin Pathol 2007; 60:1112-6; PMID: 17182662; http://dx.doi.org/10.1136/jcp.2006.044537